Discontinued — last reported Q2 '25
Equity
Redeemable NCI
McKesson Redeemable NCI increased by 3.2% to $802.00M in Q4 2025 compared to the prior quarter. Over 2 years (FY 2020 to FY 2025), Redeemable NCI shows a downward trend with a -21.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ4 2023
Last reportedQ2 2025
How to read this metric
An increase indicates a potential future cash outflow obligation, which could impact liquidity.
Detailed definition
This represents equity interests in subsidiaries held by third parties that have redemption features, allowing the holde...
Peer comparison
Common in companies with complex joint ventures or partially owned subsidiaries.
Metric ID:
redeemable_noncontrolling_interestsHistorical Data
8 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|
| Value | $7.00M | $0.00 | $0.00 | $0.00 | $0.00 | $725.00M | $777.00M | $802.00M |
| QoQ Change | — | -100.0% | — | — | — | — | +7.2% | +3.2% |
Range$0.00 – $802.00M
CAGR>999%
Current Streak2+ quarters growth
Redeemable NCI at Other Companies
Frequently Asked Questions
- What is McKesson's redeemable nci?
- McKesson (MCK) reported redeemable nci of $802.00M in Q4 2025.
- What is the long-term trend for McKesson's redeemable nci?
- Over 2 years (2020 to 2025), McKesson's redeemable nci has grown at a -21.2% compound annual growth rate (CAGR), from $1.29B to $802.00M.
- What does redeemable nci mean?
- Equity held by others in a subsidiary that the company may be required to repurchase.